Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
Journal
PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
08
11
2022
accepted:
12
07
2023
revised:
21
08
2023
medline:
22
8
2023
pubmed:
9
8
2023
entrez:
9
8
2023
Statut:
epublish
Résumé
The impact of variants of concern (VoC) on SARS-CoV-2 viral dynamics remains poorly understood and essentially relies on observational studies subject to various sorts of biases. In contrast, experimental models of infection constitute a powerful model to perform controlled comparisons of the viral dynamics observed with VoC and better quantify how VoC escape from the immune response. Here we used molecular and infectious viral load of 78 cynomolgus macaques to characterize in detail the effects of VoC on viral dynamics. We first developed a mathematical model that recapitulate the observed dynamics, and we found that the best model describing the data assumed a rapid antigen-dependent stimulation of the immune response leading to a rapid reduction of viral infectivity. When compared with the historical variant, all VoC except beta were associated with an escape from this immune response, and this effect was particularly sensitive for delta and omicron variant (p<10-6 for both). Interestingly, delta variant was associated with a 1.8-fold increased viral production rate (p = 0.046), while conversely omicron variant was associated with a 14-fold reduction in viral production rate (p<10-6). During a natural infection, our models predict that delta variant is associated with a higher peak viral RNA than omicron variant (7.6 log10 copies/mL 95% CI 6.8-8 for delta; 5.6 log10 copies/mL 95% CI 4.8-6.3 for omicron) while having similar peak infectious titers (3.7 log10 PFU/mL 95% CI 2.4-4.6 for delta; 2.8 log10 PFU/mL 95% CI 1.9-3.8 for omicron). These results provide a detailed picture of the effects of VoC on total and infectious viral load and may help understand some differences observed in the patterns of viral transmission of these viruses.
Identifiants
pubmed: 37556476
doi: 10.1371/journal.pcbi.1010721
pii: PCOMPBIOL-D-22-01635
pmc: PMC10441782
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1010721Informations de copyright
Copyright: © 2023 Marc et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Euro Surveill. 2021 Jun;26(24):
pubmed: 34142653
Nat Commun. 2022 Jan 24;13(1):460
pubmed: 35075154
PLoS Comput Biol. 2021 Mar 17;17(3):e1008785
pubmed: 33730053
J Med Virol. 2022 Aug;94(8):3625-3633
pubmed: 35373851
PNAS Nexus. 2022 May 23;1(2):pgac067
pubmed: 36713328
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2203760119
pubmed: 35867811
Clin Microbiol Infect. 2021 Apr;27(4):511-519
pubmed: 33484843
Nat Commun. 2021 Oct 20;12(1):6097
pubmed: 34671037
Nature. 2021 Nov;599(7883):114-119
pubmed: 34488225
Lancet. 2022 Apr 16;399(10334):1513-1536
pubmed: 35279232
CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):318-329
pubmed: 33755345
Front Immunol. 2022 Feb 09;13:801522
pubmed: 35222380
Nat Commun. 2023 Feb 14;14(1):824
pubmed: 36788246
Euro Surveill. 2021 Sep;26(37):
pubmed: 34533119
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
J Biol Dyn. 2021 May;15(sup1):S248-S272
pubmed: 33847236
PLoS Biol. 2021 Jul 12;19(7):e3001333
pubmed: 34252080
Nat Med. 2022 May;28(5):1031-1041
pubmed: 35361992
Environ Int. 2020 Nov;144:106039
pubmed: 32822927
Nat Microbiol. 2022 Aug;7(8):1161-1179
pubmed: 35798890
medRxiv. 2021 Sep 15;:
pubmed: 34545376
Nat Med. 2021 Jul;27(7):1230-1238
pubmed: 34035535
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49):
pubmed: 34857628
Cytokine Growth Factor Rev. 2008 Apr;19(2):121-32
pubmed: 18321765
CPT Pharmacometrics Syst Pharmacol. 2020 Sep;9(9):509-514
pubmed: 32558354
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):
pubmed: 33536313
Nature. 2020 Sep;585(7826):584-587
pubmed: 32698191
N Engl J Med. 2022 Feb 24;386(8):744-756
pubmed: 34986294